Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificial intelligence to find patients who can benefit.
This content was published on
2 minutes
Bloomberg
When given after surgery to remove lung tumours, Roche’s Alecensa cut the risk of either cancer recurrence or death by 76% compared with standard chemotherapy, according to results from a primary analysis of the trial released Wednesday. The drug could “potentially alter the course of this disease,” Roche Chief Medical Officer Levi Garraway said in a statement.
But finding patients to treat may be difficult: the study examined the effects on people with an error in a gene called ALK that’s found in only about 4% to 5% of lung cancer patients. Most of them are younger and less likely to have smoked than typical lung tumour patients, and often go undiagnosed early on.
To solve the problem, Roche will use an AI collaboration with Israeli tech company Medial EarlySign Ltd. to help doctors determine when to use CT scans. While the technology, called LungFlag, doesn’t currently detect ALK-positive patients, the company said on Saturday that it’s actively exploring how to expand it so they can benefit.
That will help find tumours before they spread and while needed surgery is still possible, said Charlie Fuchs, Roche’s head of oncology and haematology drug development.
“Sometimes when you really use deep data algorithms, you may find things that identify people who are non-smokers and yet at risk,” Fuchs said in an interview. “We hope more patients can be found early and benefit from this.”
Roche has said it will file the Alecensa study results with regulators for approval. The full results were presented Saturday at the European Society for Medical Oncology meeting in Madrid. Alecensa is already approved in the US, Europe, Japan and China for patients with ALK-positive metastatic lung cancer.
Analysts anticipate that Alecensa will generate CHF1.56 billion ($1.75 billion) in sales this year. That it would be a blockbuster medicine even though it treats such a small portion of lung cancer patients shows that effective drugs don’t have to serve a big patient population to be scientific and financial successes, Fuchs said.
One person consumes 4.8 megawatt hours of electricity
This content was published on
On average, the Swiss consume 4.8 megawatt hours of electricity per year. According to Velobiz.de, this is roughly equivalent to the amount generated by all 176 cyclists in the Tour de France during the entire race.
Outgoing ICRC chief in Ukraine defends neutrality amid war
This content was published on
Swiss national Jürg Eglin, outgoing head of the International Committee of the Red Cross in Ukraine, reflects on his tenure.
Green party leader criticises government’s neo-liberal policy
This content was published on
The Green Party delegates' meeting opened on Saturday morning in Vicques (JU) with a speech by party president Lisa Mazzone. Mazzone took particular aim at the Federal Council's policy towards the United States.
Working on Sundays is detrimental to well-being, says Swiss study
This content was published on
A study by the University of Bern shows that working on Sundays is detrimental to well-being and particularly affects women.
Safra Sarasin private bank and former asset manager sentenced
This content was published on
The Office of the Attorney General of Switzerland has fined private bank J. Safra Sarasin CHF3.5 million for aggravated money laundering. A former bank employee received a six-month suspended prison sentence.
JPMorgan to pay CHF270 million to settle 1MDB claims
This content was published on
JPMorgan Chase has agreed to pay CHF270 million to the Malaysian government to settle all issues related to its role in the 1MDB financial scandal.
Famine confirmed in Gaza for first time, says UN-backed report
This content was published on
Famine has been declared in a northern part of the Gaza Strip, according to the Integrated Food Security Phase Classification (IPC) system.
Zurich Airport ground handling staff to strike on Friday
This content was published on
Ground handling staff at Zurich Airport have announced a strike for Friday afternoon. According to a union, 200 jobs are at risk.
This content was published on
Philippe Lazzarini will step down as head of the United Nations Relief and Works Agency for Palestinian Refugees (UNRWA) at the end of his term in March, he announced on Thursday.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.